Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBERT L GOTTLIEB

Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology

NPI
1386855922
CMS profile
914971
Location
DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$219,676.93

142 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $128,933.83 75
Alnylam Pharmaceuticals Inc. $58,020.14 56
ABBVIE INC. $18,400.00 4
Janssen Research & Development, LLC $10,000.00 1
AstraZeneca Pharmaceuticals LP $2,693.85 2
Eli Lilly and Company $1,575.00 1
Novartis Pharmaceuticals Corporation $37.29 2
Novo Nordisk Inc $16.82 1

Page 3 of 3; records 101–142 of 142 matching records. This page contains 42 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBERT L GOTTLIEB

NPI 1386855922 · CMS profile ID 914971

Allopathic & Osteopathic Physicians / Internal Medicine / Advanced Heart Failure and Transplant Cardiology

DALLAS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–142 of 142 matching records. This page contains 42 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1386855922?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBERT L GOTTLIEB, NPI 1386855922, CMS profile ID 914971. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–142 of 142 matching records. This page contains 42 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1386855922?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ROBERT L GOTTLIEB, NPI 1386855922, CMS profile ID 914971. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–142 of 142 matching records. This page contains 42 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1386855922?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ROBERT L GOTTLIEB, NPI 1386855922, CMS profile ID 914971, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–142 of 142 matching records. This page contains 42 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1386855922?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

142 matching records · $219,676.93 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 142 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–142 of 142.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Gilead Sciences, Inc. $37.8904/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488611 CMS
Gilead Sciences, Inc. $44.3704/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025536419 CMS
Gilead Sciences, Inc. $21.2304/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488601 CMS
Gilead Sciences, Inc. $26.5704/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488603 CMS
Gilead Sciences, Inc. $289.0004/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488605 CMS
Gilead Sciences, Inc. $441.2804/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488609 CMS
Gilead Sciences, Inc. $108.0804/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025520831 CMS
Gilead Sciences, Inc. $37.2704/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025539115 CMS
Gilead Sciences, Inc. $16.0904/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025959661 CMS
Gilead Sciences, Inc. $506.7604/15/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026303839 CMS
Gilead Sciences, Inc. $35.3604/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488591 CMS
Gilead Sciences, Inc. $2,459.9604/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488595 CMS
Gilead Sciences, Inc. $2,484.4804/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488597 CMS
Gilead Sciences, Inc. $26.0304/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025603501 CMS
Gilead Sciences, Inc. $7.0004/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488575 CMS
Gilead Sciences, Inc. $35.3704/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488577 CMS
Gilead Sciences, Inc. $111.0004/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488581 CMS
Gilead Sciences, Inc. $193.2104/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488583 CMS
Gilead Sciences, Inc. $259.9004/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488585 CMS
Gilead Sciences, Inc. $5,461.4904/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025488589 CMS
Gilead Sciences, Inc. $8.7104/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026082125 CMS
Alnylam Pharmaceuticals Inc. $98.3704/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139801 CMS
Gilead Sciences, Inc. $9,120.0004/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1035502619 CMS
Alnylam Pharmaceuticals Inc. $19.1804/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139941 CMS
Alnylam Pharmaceuticals Inc. $27.0604/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139957 CMS
Alnylam Pharmaceuticals Inc. $50.0004/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139961 CMS
Alnylam Pharmaceuticals Inc. $68.9404/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139967 CMS
ABBVIE INC. $800.0003/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997373459 CMS
Gilead Sciences, Inc. $71.1403/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025528485 CMS
Alnylam Pharmaceuticals Inc. $1,763.0003/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139765 CMS
Alnylam Pharmaceuticals Inc. $4,935.0003/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139977 CMS
Alnylam Pharmaceuticals Inc. $607.8103/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139981 CMS
Alnylam Pharmaceuticals Inc. $111.1003/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139987 CMS
Alnylam Pharmaceuticals Inc. $80.0003/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139991 CMS
Alnylam Pharmaceuticals Inc. $18.8103/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139997 CMS
Alnylam Pharmaceuticals Inc. $47.9502/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139725 CMS
Alnylam Pharmaceuticals Inc. $3,525.0002/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139731 CMS
Alnylam Pharmaceuticals Inc. $10.7202/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139735 CMS
Alnylam Pharmaceuticals Inc. $243.6602/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139741 CMS
Alnylam Pharmaceuticals Inc. $87.6102/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139693 CMS
Alnylam Pharmaceuticals Inc. $21.3202/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006139697 CMS
Gilead Sciences, Inc. $4,860.0002/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1035502613 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $65,431.72 181
PY2020 $34,374.10 24
PY2021 $93,330.11 43
PY2022 $75,054.49 61
PY2023 $219,676.93 142
PY2024 $82,894.10 86
PY2025 $146,315.98 127

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $55,886.00 7
PY2024 Principal investigator $55,681.45 5
PY2023 Recipient $26,794.22 5
PY2023 Principal investigator $379,370.67 38
PY2022 Recipient $299.55 1
PY2022 Principal investigator $726,042.18 64
PY2021 Recipient $2,491.43 3
PY2021 Principal investigator $5,523,764.27 158
PY2020 Recipient $138,375.71 4
PY2020 Principal investigator $6,587,350.82 126
PY2019 Principal investigator $65,260.43 35

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $975.00 11/21/2025 Non-covered Recipient Entity
BAYLOR SCOTT & WHITE RESEARCH INSTI
Phase 2 Randomized Double blind Placebo controlled Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed COVID19 Severe Disease No dispute reported 06/30/2026 1175403820
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $5,070.00 11/12/2025 Non-covered Recipient Entity
Baylor Research Institute
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy No dispute reported 06/30/2026 1235998744
Principal investigator 1 SANOFI US SERVICES INC. $1,000.00 08/06/2025 Non-covered Recipient Entity
Multiple Sclerosis Treatment Center Of Dallas
Fabry Disease Registry Protocol No dispute reported 06/30/2026 1226097266
Principal investigator 1 SANOFI US SERVICES INC. $50.00 07/30/2025 Non-covered Recipient Entity
Multiple Sclerosis Treatment Center Of Dallas
Fabry Disease Registry Protocol No dispute reported 06/30/2026 1226097258
Principal investigator 1 SANOFI US SERVICES INC. $300.00 06/23/2025 Non-covered Recipient Entity
Multiple Sclerosis Treatment Center Of Dallas
Fabry Disease Registry Protocol No dispute reported 06/30/2026 1226109236
Principal investigator 1 AstraZeneca UK Limited $24,140.00 04/23/2025 Non-covered Recipient Entity
BAYLOR SCOTT AND WHITE RESEARCH INSTITUTE
A Phase I-III Randomized Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156-AZD3152 for Pre exposure Prophylaxis of COVID 19 in Participants with Conditions Causing Immune Impairment No dispute reported 06/30/2026 1185542960
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $24,351.00 01/17/2025 Non-covered Recipient Entity
Baylor Research Institute
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM) (DISCOVER-HCM) No dispute reported 06/30/2026 1235998742